1. Preface
     1.1. Report Scope and Market Segmentation
     1.2. Research Highlights

2. Assumptions and Research Methodology
     2.1. Assumptions
     2.2. Acronyms Used
     2.3. Research Methodology

3. Executive Summary
     3.1. Global Anti-infective Drugs Market Snapshot
     3.2. Market Opportunity Map

4. Market Overview
     4.1. Product Overview
     4.2. Global Anti-infective Drugs Market Size (US$ Mn) Forecast, 2017–2025
     4.3. Global Anti-infective Drugs Market Outlook
     4.4. Key Industry Developments

5. Market Dynamics
     5.1. Drivers and Restraints Snapshot Analysis
     5.2. Drivers
     5.3. Restraints
     5.4. Opportunities
     5.5. Key Trends
     5.6. Porter’s Analysis
     5.7. Pipeline Analysis
     5.8. Disease Prevalence
     5.9. Key Brand Analysis

6. Global Anti-infective Drugs Market Analysis, by Type
     6.1. Key Findings
     6.2. Introduction
     6.3. Anti-infective Drugs Market Value Share Analysis, by Type
     6.4. Anti-infective Drugs Market Forecast, by Type
           6.4.1. Global Anti-infective Drugs Market Forecast, by Type - Anti-bacterial Drugs
                     6.4.1.1. B - Lactams
                     6.4.1.2. Quinolones
                     6.4.1.3. Macrolides
                     6.4.1.4. Tetracycline
                     6.4.1.5. Aminoglycoside
                     6.4.1.6. Others (Sulfonamide, Phenicols)
           6.4.2. Global Anti-infective Drugs Market Forecast, by Type - Anti-fungal Drugs
                     6.4.2.1. Azoles
                     6.4.2.2. Echinocandins
                     6.4.2.3. Polyenes
                     6.4.2.4. Others
           6.4.3. Global Anti-infective Drugs Market Forecast, by Type - Anti-viral Drugs
     6.5. Anti-infective Drugs Market Analysis, by Type
     6.6. Anti-infective Drugs Market Attractiveness Analysis, by Type
     6.7. Market Trends

7. Anti-infective Drugs Market Analysis, by Disease Indication
     7.1. Key Findings
     7.2. Introduction
     7.3. Anti-infective Drugs Market Value Share Analysis, by Disease Indication
     7.4. Anti-infective Drugs Market Forecast, by Disease Indication
           7.4.1. Pneumonia
           7.4.2. Methicillin-resistant Staphylococcus Aureus (MRSA)
           7.4.3. Sepsis
           7.4.4. Tuberculosis
           7.4.5. Dermatophytosis
           7.4.6. Aspergillosis
           7.4.7. Candidiasis
           7.4.8. Hepatitis Virus Infection
           7.4.9. HIV Infection
           7.4.10. Respiratory Virus Infection
           7.4.11. Others
     7.5. Anti-infective Drugs Market Analysis, by Disease Indication
     7.6. Anti-infective Drugs Market Attractiveness Analysis, by Disease Indication
     7.7. Key Trends

8. Anti-infective Drugs Market Analysis, by Distribution Channel
     8.1. Key Findings
     8.2. Introduction
     8.3. Anti-infective Drugs Market Value Share Analysis, by Distribution Channel
     8.4. Anti-infective Drugs Market Forecast, by Distribution Channel
           8.4.1. Hospital Pharmacy
           8.4.2. Retail Pharmacy
           8.4.3. Online Sales
     8.5. Anti-infective Drugs Market Analysis, by Distribution Channel
     8.6. Anti-infective Drugs Market Attractiveness Analysis, by Distribution Channel
     8.7. Market Trends

9. Anti-infective Drugs Market Analysis, by Region
     9.1. Global Market Scenario
     9.2. Anti-infective Drugs Market Value Share Analysis, by Region
     9.3. Anti-infective Drugs Market Forecast, by Region
           9.3.1. North America
           9.3.2. Europe
           9.3.3. Asia Pacific
           9.3.4. Latin America
           9.3.5. Middle East & Africa
     9.4. Anti-infective Drugs Market Attractiveness Analysis, by Region

10. North America Anti-infective Drugs Market Analysis
     10.1. Key Findings
     10.2. North America Anti-infective Drugs Market Overview
     10.3. North America Anti-infective Drugs Market Value Share Analysis, by Country
     10.4. North America Anti-infective Drugs Market Forecast, by Country
           10.4.1. U.S.
           10.4.2. Canada
     10.5. North America Anti-infective Drugs Market Value Share Analysis, by Type
     10.6. North America Anti-infective Drugs Market Forecast, by Type
           10.6.1. North America Anti-infective Drugs Market Value Share Analysis, by Type - Anti-bacterial Drugs
           10.6.2. North America Anti-infective Drugs Market Forecast, by Type - Anti-bacterial Drugs
                     10.6.2.1. B - Lactams
                     10.6.2.2. Quinolones
                     10.6.2.3. Macrolides
                     10.6.2.4. Tetracycline
                     10.6.2.5. Aminoglycoside
                     10.6.2.6. Others (Sulfonamide, Phenicols)
           10.6.3. North America Anti-infective Drugs Market Value Share Analysis, by Type - Anti-fungal Drugs
           10.6.4. North America Anti-infective Drugs Market Forecast, by Type - Anti-fungal Drugs
                     10.6.4.1. Azoles
                     10.6.4.2. Echinocandins
                     10.6.4.3. Polyenes
                     10.6.4.4. Others
           10.6.5. North America Anti-infective Drugs Market Forecast, by Type - Anti-viral Drugs
     10.7. North America Anti-infective Drugs Market Value Share Analysis, by Indication
     10.8. North America Anti-infective Drugs Market Forecast, by Indication
           10.8.1. Pneumonia
           10.8.2. Methicillin-resistant Staphylococcus Aureus (MRSA)
           10.8.3. Sepsis
           10.8.4. Tuberculosis
           10.8.5. Dermatophytosis
           10.8.6. Aspergillosis
           10.8.7. Candidiasis
           10.8.8. Hepatitis Virus Infection
           10.8.9. HIV Infection
           10.8.10. Respiratory Virus Infection
           10.8.11. Others
     10.9. North America Anti-infective Drugs Market Value Share Analysis, by Distribution Channel
     10.10. North America Anti-infective Drugs Market Forecast, by Distribution Channel
           10.10.1. Hospital Pharmacy
           10.10.2. Retail Pharmacy
           10.10.3. Online Sales
     10.11. North America Anti-infective Drugs Market Attractiveness Analysis

11. Europe Anti-infective Drugs Market Analysis
     11.1. Key Findings
     11.2. Europe Anti-infective Drugs Market Overview
     11.3. Europe Anti-infective Drugs Market Value Share Analysis, by Country
     11.4. Europe Anti-infective Drugs Market Forecast, by Country
           11.4.1. U.K.
           11.4.2. Germany
           11.4.3. France
           11.4.4. Italy
           11.4.5. Spain
           11.4.6. Rest of Europe
     11.5. Europe Anti-infective Drugs Market Value Share Analysis, by Type
     11.6. Europe Anti-infective Drugs Market Forecast, by Type
           11.6.1. Europe Anti-infective Drugs Market Value Share Analysis, by Type - Anti-bacterial Drugs
           11.6.2. Europe Anti-infective Drugs Market Forecast, by Type - Anti-bacterial Drugs
                     11.6.2.1. B - Lactams
                     11.6.2.2. Quinolones
                     11.6.2.3. Macrolides
                     11.6.2.4. Tetracycline
                     11.6.2.5. Aminoglycoside
                     11.6.2.6. Others (Sulfonamide, Phenicols)
           11.6.3. Europe Anti-infective Drugs Market Value Share Analysis, by Type - Anti-fungal Drugs
           11.6.4. Europe Anti-infective Drugs Market Forecast, by Type - Anti-fungal Drugs
                     11.6.4.1. Azoles
                     11.6.4.2. Echinocandins
                     11.6.4.3. Polyenes
                     11.6.4.4. Others
           11.6.5.  Europe Anti-infective Drugs Market Forecast, by Type - Anti-viral Drugs
     11.7. Europe Anti-infective Drugs Market Value Share Analysis, by Indication
     11.8. Europe Anti-infective Drugs Market Forecast, by Indication
           11.8.1. Pneumonia
           11.8.2. Methicillin-resistant Staphylococcus Aureus (MRSA)
           11.8.3. Sepsis
           11.8.4. Tuberculosis
           11.8.5. Dermatophytosis
           11.8.6. Aspergillosis
           11.8.7. Candidiasis
           11.8.8. Hepatitis Virus Infection
           11.8.9. HIV Infection
           11.8.10. Respiratory Virus Infection
           11.8.11. Others
     11.9. Europe Anti-infective Drugs Market Value Share Analysis, by Distribution Channel
     11.10. Europe Anti-infective Drugs Market Forecast, by Distribution Channel
           11.10.1. Hospital Pharmacy
           11.10.2. Retail Pharmacy
           11.10.3. Online Sales
     11.11. Europe Anti-infective Drugs Market Attractiveness Analysis

12. Asia Pacific Anti-infective Drugs Market Analysis
     12.1. Key Findings
     12.2. Asia Pacific Anti-infective Drugs Market Overview
     12.3. Asia Pacific Anti-infective Drugs Market Value Share Analysis, by Country
     12.4. Asia Pacific rope Anti-infective Drugs Market Forecast, by Country
           12.4.1. China
           12.4.2. Japan
           12.4.3. India
           12.4.4. Australia & New Zealand
           12.4.5. Rest of APAC
     12.5. Asia Pacific Anti-infective Drugs Market Value Share Analysis, by Type
     12.6. Asia Pacific Anti-infective Drugs Market Forecast, by Type
           12.6.1. Asia Pacific Anti-infective Drugs Market Value Share Analysis, by Type - Anti-bacterial Drugs
           12.6.2. Asia Pacific Anti-infective Drugs Market Forecast, by Type - Anti-bacterial Drugs
                     12.6.2.1. B - Lactams
                     12.6.2.2. Quinolones
                     12.6.2.3. Macrolides
                     12.6.2.4. Tetracycline
                     12.6.2.5. Aminoglycoside
                     12.6.2.6. Others (Sulfonamide, Phenicols)
           12.6.3. Asia Pacific Anti-infective Drugs Market Value Share Analysis, by Type - Anti-fungal Drugs
           12.6.4. Asia Pacific Anti-infective Drugs Market Forecast, by Type - Anti-fungal Drugs
                     12.6.4.1. Azoles
                     12.6.4.2. Echinocandins
                     12.6.4.3. Polyenes
                     12.6.4.4. Others
           12.6.5.  Asia Pacific Anti-infective Drugs Market Forecast, by Type - Anti-viral Drugs
     12.7. Asia Pacific Anti-infective Drugs Market Value Share Analysis, by Indication
     12.8. Asia Pacific Anti-infective Drugs Market Forecast, by Indication
           12.8.1. Pneumonia
           12.8.2. Methicillin-resistant Staphylococcus Aureus (MRSA)
           12.8.3. Sepsis
           12.8.4. Tuberculosis
           12.8.5. Dermatophytosis
           12.8.6. Aspergillosis
           12.8.7. Candidiasis
           12.8.8. Hepatitis Virus Infection
           12.8.9. HIV Infection
           12.8.10. Respiratory Virus Infection
           12.8.11. Others
     12.9. Asia Pacific Anti-infective Drugs Market Value Share Analysis, by Distribution Channel
     12.10. Asia Pacific Anti-infective Drugs Market Forecast, by Distribution Channel
           12.10.1. Hospital Pharmacy
           12.10.2. Retail Pharmacy
           12.10.3. Online Sales
     12.11. Asia Pacific Anti-infective Drugs Market Attractiveness Analysis

13. Latin America Anti-infective Drugs Market Analysis
     13.1. Key Findings
     13.2. Latin America Anti-infective Drugs Market Overview
     13.3. Latin America Anti-infective Drugs Market Value Share Analysis, by Country
     13.4. Latin America Anti-infective Drugs Market Forecast, by Country
           13.4.1. Brazil
           13.4.2. Mexico
           13.4.3. Rest of LATAM
     13.5. Latin America Anti-infective Drugs Market Value Share Analysis, by Type
     13.6. Latin America Anti-infective Drugs Market Forecast, by Type
           13.6.1. Latin America Anti-infective Drugs Market Value Share Analysis, by Type - Anti-bacterial Drugs
           13.6.2. Latin America Anti-infective Drugs Market Forecast, by Type - Anti-bacterial Drugs
                     13.6.2.1. B - Lactams
                     13.6.2.2. Quinolones
                     13.6.2.3. Macrolides
                     13.6.2.4. Tetracycline
                     13.6.2.5. Aminoglycoside
                     13.6.2.6. Others (Sulfonamide, Phenicols)
           13.6.3. Latin America Anti-infective Drugs Market Value Share Analysis, by Type - Anti-fungal Drugs
           13.6.4. Latin America Anti-infective Drugs Market Forecast, by Type - Anti-fungal Drugs
                     13.6.4.1. Azoles
                     13.6.4.2. Echinocandins
                     13.6.4.3. Polyenes
                     13.6.4.4. Others
           13.6.5.  Latin America Anti-infective Drugs Market Forecast, by Type - Anti-viral Drugs
     13.7. Latin America Anti-infective Drugs Market Value Share Analysis, by Indication
     13.8. Latin America Anti-infective Drugs Market Forecast, by Indication
           13.8.1. Pneumonia
           13.8.2. Methicillin-resistant Staphylococcus Aureus (MRSA)
           13.8.3. Sepsis
           13.8.4. Tuberculosis
           13.8.5. Dermatophytosis
           13.8.6. Aspergillosis
           13.8.7. Candidiasis
           13.8.8. Hepatitis Virus Infection
           13.8.9. HIV Infection
           13.8.10. Respiratory Virus Infection
           13.8.11. Others
     13.9. Latin America Anti-infective Drugs Market Value Share Analysis, by Distribution Channel
     13.10. Latin America Anti-infective Drugs Market Forecast, by Distribution Channel
           13.10.1. Hospital Pharmacy
           13.10.2. Retail Pharmacy
           13.10.3. Online Sales
     13.11. Latin America Anti-infective Drugs Market Attractiveness Analysis

14. Middle East & Africa Anti-infective Drugs Market Analysis
     14.1. Key Findings
     14.2. Middle East & Africa Anti-infective Drugs Market Overview
     14.3. Middle East & Africa Anti-infective Drugs Market Value Share Analysis, by Country
     14.4. Middle East & Africa Anti-infective Drugs Market Forecast, by Country
           14.4.1. GCC Countries
           14.4.2. South Africa
           14.4.3. Rest of MEA
     14.5. Middle East & Africa Anti-infective Drugs Market Value Share Analysis, by Type
     14.6. Middle East & Africa Anti-infective Drugs Market Forecast, by Type
           14.6.1. Middle East & Africa Anti-infective Drugs Market Value Share Analysis, by Type - Anti-bacterial Drugs
           14.6.2. Middle East & Africa Anti-infective Drugs Market Forecast, by Type - Anti-bacterial Drugs
                     14.6.2.1. B - Lactams
                     14.6.2.2. Quinolones
                     14.6.2.3. Macrolides
                     14.6.2.4. Tetracycline
                     14.6.2.5. Aminoglycoside
                     14.6.2.6. Others (Sulfonamide, Phenicols)
           14.6.3. Middle East & Africa Anti-infective Drugs Market Value Share Analysis, by Type - Anti-fungal Drugs
           14.6.4. Middle East & Africa Anti-infective Drugs Market Forecast, by Type - Anti-fungal Drugs
                     14.6.4.1. Azoles
                     14.6.4.2. Echinocandins
                     14.6.4.3. Polyenes
                     14.6.4.4. Others
           14.6.5.  Middle East & Africa Anti-infective Drugs Market Forecast, by Type - Anti-viral Drugs
     14.7. Middle East & Africa Anti-infective Drugs Market Value Share Analysis, by Indication
     14.8. Middle East & Africa Anti-infective Drugs Market Forecast, by Indication
           14.8.1. Pneumonia
           14.8.2. Methicillin-resistant Staphylococcus Aureus (MRSA)
           14.8.3. Sepsis
           14.8.4. Tuberculosis
           14.8.5. Dermatophytosis
           14.8.6. Aspergillosis
           14.8.7. Candidiasis
           14.8.8. Hepatitis Virus Infection
           14.8.9. HIV Infection
           14.8.10. Respiratory Virus Infection
           14.8.11. Others
     14.9. Middle East & Africa Anti-infective Drugs Market Value Share Analysis, by Distribution Channel
           14.9.1. Hospital Pharmacy
           14.9.2. Retail Pharmacy
           14.9.3. Online Sales
     14.10. Middle East & Africa Anti-infective Drugs Market Forecast, by Distribution Channel
     14.11. Middle East & Africa Anti-infective Drugs Market Attractiveness Analysis

15. Competition Matrix
     15.1. Anti-infective Drugs Market Share Analysis, by Company, 2016
     15.2. Company Profiles
           15.2.1. Merck & Co., Inc.
                     15.2.1.1. Company Profiles
                     15.2.1.2. Business Overview
                     15.2.1.3. Strategic Overview
                     15.2.1.4. SWOT Analysis
     15.3. Bayer AG
                     15.3.1.1. Company Profiles
                     15.3.1.2. Business Overview
                     15.3.1.3. Strategic Overview
                     15.3.1.4. SWOT Analysis
     15.4. Pfizer, Inc.
                     15.4.1.1. Company Profiles
                     15.4.1.2. Business Overview
                     15.4.1.3. Strategic Overview
                     15.4.1.4. SWOT Analysis
     15.5. Gilead Sciences
                     15.5.1.1. Company Profiles
                     15.5.1.2. Business Overview
                     15.5.1.3. Strategic Overview
                     15.5.1.4. SWOT Analysis
     15.6. GlaxoSmithKline plc
                     15.6.1.1. Company Profiles
                     15.6.1.2. Business Overview
                     15.6.1.3. Strategic Overview
                     15.6.1.4. SWOT Analysis
     15.7. Novartis AG
                     15.7.1.1. Company Profiles
                     15.7.1.2. Business Overview
                     15.7.1.3. Strategic Overview
                     15.7.1.4. SWOT Analysis
     15.8. Bristol-Myers Squibb Co
                     15.8.1.1. Company Profiles
                     15.8.1.2. Business Overview
                     15.8.1.3. Strategic Overview
                     15.8.1.4. SWOT Analysis
     15.9. Sanofi
                     15.9.1.1. Company Profiles
                     15.9.1.2. Business Overview
                     15.9.1.3. Strategic Overview
                     15.9.1.4. SWOT Analysis
     15.10. Allergen plc
                     15.10.1.1. Company Profiles
                     15.10.1.2. Business Overview
                     15.10.1.3. Strategic Overview
                     15.10.1.4. SWOT Analysis
     15.11. F. Hoffman-La Roche Ltd.
                     15.11.1.1. Company Profiles
                     15.11.1.2. Business Overview
                     15.11.1.3. Strategic Overview
                     15.11.1.4. SWOT Analysis
     15.12. Johnson and Johnson
                     15.12.1.1. Company Profiles
                     15.12.1.2. Business Overview
                     15.12.1.3. Strategic Overview
                     15.12.1.4. SWOT Analysis

 

List of Tables

Table 01: Global Anti-infective Drugs Market Size (US$ Mn) Forecast, by Type, 2017–2025
Table 02: Global Anti-infective Drugs Market Size (US$ Mn) Forecast, by Type - Anti-bacterial Drugs, 2017–2025
Table 03: Global Anti-infective Drugs Market Size (US$ Mn) Forecast, by Type - Anti-fungal Drugs, 2017–2025
Table 04: Global Anti-infective Drugs Market Size (US$ Mn) Forecast, by Disease Indication, 2017–2025
Table 05: Global Anti-infective Drugs Market Size (US$ Mn) Forecast, by Distribution Channel, 2017–2025
Table 06: Global Anti-infective Drugs Market Size (US$ Mn) Forecast, by Region, 2017–2025
Table 07: North America Anti-infective Drugs Market Size (US$ Mn) Forecast, by Country, 2017–2025
Table 08: North America Anti-infective Drugs Market Size (US$ Mn) Forecast, by Type, 2017–2025
Table 09: North America Anti-infective Drugs Market Size (US$ Mn) Forecast, by Type - Anti-bacterial Drugs, 2017–2025
Table 10: North America Anti-infective Drugs Market Size (US$ Mn) Forecast, by Type - Anti-fungal Drugs, 2017–2025
Table 10: North America Anti-infective Drugs Market Size (US$ Mn) Forecast, by Indication, 2017–2025
Table 12: North America Anti-infective Drugs Market Size (US$ Mn) Forecast, by Distribution Channel, 2017–2025
Table 13: Europe Anti-infective Drugs Market Size (US$ Mn) Forecast, by Country, 2017–2025
Table 14: Europe Anti-infective Drugs Market Size (US$ Mn) Forecast, by Type, 2017–2025
Table 15: Europe Anti-infective Drugs Market Size (US$ Mn) Forecast, by Type - Anti-bacterial Drugs, 2017–2025
Table 16: Europe Anti-infective Drugs Market Size (US$ Mn) Forecast, by Type - Anti-fungal Drugs, 2017–2025
Table 17: Europe Anti-infective Drugs Market Size (US$ Mn) Forecast, by Indication, 2017–2025
Table 18: Europe Anti-infective Drugs Market Size (US$ Mn) Forecast, by Distribution Channel, 2017–2025
Table 19: Asia Pacific Anti-infective Drugs Market Size (US$ Mn) Forecast, by Country, 2017–2025
Table 20: Asia Pacific Anti-infective Drugs Market Size (US$ Mn) Forecast, by Type, 2017–2025
Table 21: Asia Pacific Anti-infective Drugs Market Size (US$ Mn) Forecast, by Type - Anti-bacterial Drugs, 2017–2025
Table 22: Asia Pacific Anti-infective Drugs Market Size (US$ Mn) Forecast, by Type - Anti-fungal Drugs, 2017–2025
Table 23: Asia Pacific Anti-infective Drugs Market Size (US$ Mn) Forecast, by Indication, 2017–2025
Table 24: Asia Pacific Anti-infective Drugs Market Size (US$ Mn) Forecast, by Distribution Channel, 2017–2025
Table 25: Latin America Anti-infective Drugs Market Size (US$ Mn) Forecast, by Country, 2017–2025
Table 26: Latin America Anti-infective Drugs Market Size (US$ Mn) Forecast, by Type, 2017–2025
Table 27: Latin America Anti-infective Drugs Market Size (US$ Mn) Forecast, by Type - Anti-bacterial Drugs, 2017–2025
Table 28: Latin America Anti-infective Drugs Market Size (US$ Mn) Forecast, by Type - Anti-fungal Drugs, 2017–2025
Table 29: Latin America Anti-infective Drugs Market Size (US$ Mn) Forecast, by Indication, 2017–2025
Table 30: Latin America Anti-infective Drugs Market Size (US$ Mn) Forecast, by Distribution Channel, 2017–2025
Table 31: Middle East & Africa Anti-infective Drugs Market Size (US$ Mn) Forecast, by Country, 2017–2025
Table 32: Middle East & Africa Anti-infective Drugs Market Size (US$ Mn) Forecast, by Type, 2017–2025
Table 33: Middle East & Africa Anti-infective Drugs Market Size (US$ Mn) Forecast, by Type - Anti-bacterial Drugs, 2017–2025
Table 34: Middle East & Africa Anti-infective Drugs Market Size (US$ Mn) Forecast, by Type - Anti-fungal Drugs, 2017–2025
Table 35: Middle East & Africa Anti-infective Drugs Market Size (US$ Mn) Forecast, by Indication, 2017–2025
Table 36: Middle East & Africa Anti-infective Drugs Market Size (US$ Mn) Forecast, by Distribution Channel, 2017–2025

 

List of Figures

Figure 01: Global Anti-infective Drugs Market Snapshot
Figure 02: Global Antiviral Drugs Market Size (US$ Mn) Forecast, 2017–2025
Figure 04: Market Value Share, by Type (2016)
Figure 06: Market Value Share, by Distribution Channel (2016)
Figure 03: Market Value Share, by Disease Indication (2016)
Figure 05: Market Value Share, by Region (2016)
Figure 07: Leading Antibacterial Drugs Sales Analysis, 2014–2016 
Figure 08: Leading Antiviral Drugs Sales Analysis, 2014–2016 
Figure 09: Global Anti-infective Drugs Market Value Share, by Product, 2016 and 2025
Figure 10: Global Anti-bacterial Drugs Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025
Figure 10: Global Anti-fungal Drugs Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025
Figure 12: Global Anti-viral Drugs Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025
Figure 13: Anti-infective Drugs Market Attractiveness Analysis, by Type, 2017–2025
Figure 14: Global Anti-infective Drugs Market Value Share, by Disease Indication, 2016 and 2025
Figure 15: Global Pneumonia - Anti-infective Drugs Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025
Figure 16: Global Methicillin-resistant Staphylococcus Aureus (MRSA) - Anti-infective Drugs Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025
Figure 17: Global Sepsis Anti-infective Drugs Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025
Figure 18: Global Tuberculosis Anti-infective Drugs Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025
Figure 19: Global Dermatophytosis- Anti-infective Drugs Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025
Figure 20: Global Aspergillosis -Anti-infective Drugs Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025
Figure 21: Global Candidiasis -Anti-infective Drugs Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025
Figure 22: Global Hepatitis Virus Infection -Anti-infective Drugs Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025
Figure 23: Global HIV Infection -Anti-infective Drugs Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025
Figure 24: Global Respiratory Virus Infection -Anti-infective Drugs Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025
Figure 25: Global Others-Anti-infective Drugs Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025
Figure 26: Anti-infective Drugs Market Attractiveness Analysis, by Disease Indication, 2017–2025
Figure 27: Global Anti-infective Drugs Market Value Share, by Distribution Channel, 2016 and 2025
Figure 28: Global Hospital Pharmacy Anti-infective Drugs Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025
Figure 29: Global Retail Pharmacy Anti-infective Drugs Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025
Figure 30: Global Online Pharmacy Anti-infective Drugs Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025
Figure 31: Anti-infective Drugs Market Attractiveness Analysis, by Distribution Channel, 2017–2025
Figure 32: Global Anti-infective Drugs Market Value Share, by Region, 2016 and 2025
Figure 33: Anti-infective Drugs Market Attractiveness Analysis, by Region, 2017–2025
Figure 34: North America Anti-infective Drugs Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2025
Figure 35: North America Anti-infective Drugs Market Attractiveness Analysis, by Country, 2016–2025
Figure 36: North America Anti-infective Drugs Market Value Share Analysis, by Country, 2016 and 2025
Figure 37: North America Anti-infective Drugs Market Value Share Analysis, by Type, 2016 and 2025
Figure 38: North America Anti-infective Drugs Market Value Share Analysis, by Anti-bacterial Drugs, 2016 and 2025
Figure 39: North America Anti-infective Drugs Market Value Share Analysis, by Type - Anti-fungal Drugs, 2016 and 2025
Figure 40: North America Anti-infective Drugs Market Value Share Analysis, by Indication, 2016 and 2025
Figure 41: North America Anti-infective Drugs Market Value Share, by Distribution Channel, 2016 and 2025
Figure 42: North America Anti-infective Drugs Market Attractiveness Analysis, by Type, 2017–2025
Figure 43: North America Anti-infective Drugs Market Attractiveness Analysis, by Indication, 2017–2025
Figure 44: North America Anti-infective Drugs Market Attractiveness Analysis, by Distribution Channel, 2017–2025
Figure 45: Europe Anti-infective Drugs Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2025
Figure 46: Europe Anti-infective Drugs Market Attractiveness Analysis, by Country, 2016–2025
Figure 47: Europe Anti-infective Drugs Market Value Share Analysis, by Country, 2016 and 2025
Figure 48: Europe Anti-infective Drugs Market Value Share Analysis, by Type, 2016 and 2025
Figure 49: Europe Anti-infective Drugs Market Value Share Analysis, by Anti-bacterial Drugs, 2016 and 2025
Figure 50: Europe Anti-infective Drugs Market Value Share Analysis, by Type - Anti-fungal Drugs, 2016 and 2025
Figure 51: Europe Anti-infective Drugs Market Value Share Analysis, by Indication, 2016 and 2025
Figure 52: Europe Anti-infective Drugs Market Value Share, by Distribution Channel, 2016 and 2025
Figure 53: Europe Anti-infective Drugs Market Attractiveness Analysis, by Type, 2016–2025
Figure 54: Europe Anti-infective Drugs Market Attractiveness Analysis, by Indication, 2016–2025
Figure 55: Europe Anti-infective Drugs Market Attractiveness Analysis, by Distribution Channel, 2016–2025
Figure 56: Asia Pacific Anti-infective Drugs Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2025
Figure 57: Asia Pacific Anti-infective Drugs Market Attractiveness Analysis, by Country, 2016–2025
Figure 58: Asia Pacific Anti-infective Drugs Market Value Share Analysis, by Country, 2016 and 2025
Figure 59: Asia Pacific Anti-infective Drugs Market Value Share Analysis, by Type, 2016 and 2025
Figure 60: Asia Pacific Anti-infective Drugs Market Value Share Analysis, by Anti-bacterial Drugs, 2016 and 2025
Figure 61: Asia Pacific Anti-infective Drugs Market Value Share Analysis, by Type - Anti-fungal Drugs, 2016 and 2025
Figure 62: Asia Pacific Anti-infective Drugs Market Value Share Analysis, by Indication, 2016 and 2025
Figure 63: Asia Pacific Anti-infective Drugs Market Value Share, by Distribution Channel, 2016 and 2025
Figure 64: Asia Pacific Anti-infective Drugs Market Attractiveness Analysis, by Type, 2017–2025
Figure 65: Asia Pacific Anti-infective Drugs Market Attractiveness Analysis, by Indication, 2017–2025
Figure 66: Asia Pacific Anti-infective Drugs Market Attractiveness Analysis, by Distribution Channel, 2017–2025
Figure 67: Latin America Anti-infective Drugs Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2025
Figure 68: Latin America Anti-infective Drugs Market Attractiveness Analysis, by Country, 2016–2025
Figure 69: Latin America Anti-infective Drugs Market Value Share Analysis, by Country, 2016 and 2025
Figure 70: Latin America Anti-infective Drugs Market Value Share Analysis, by Type, 2016 and 2025
Figure 71: Latin America Anti-infective Drugs Market Value Share Analysis, by Anti-bacterial Drugs, 2016 and 2025
Figure 72: Latin America Anti-infective Drugs Market Value Share Analysis, by Type - Anti-fungal Drugs, 2016 and 2025
Figure 73: Latin America Anti-infective Drugs Market Value Share Analysis, by Indication, 2016 and 2025
Figure 74: Latin America Anti-infective Drugs Market Value Share, by Distribution Channel, 2016 and 2024
Figure 75: Latin America Anti-infective Drugs Market Attractiveness Analysis, by Type, 2017–2025
Figure 76: Latin America Anti-infective Drugs Market Attractiveness Analysis, by Indication, 2017–2025
Figure 77: Latin America Anti-infective Drugs Market Attractiveness Analysis, by Distribution Channel, 2016–2024
Figure 78: Middle East & Africa Anti-infective Drugs Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2025
Figure 79: Middle East & Africa Anti-infective Drugs Market Attractiveness Analysis, by Country, 2016–2025
Figure 80: Middle East & Africa Anti-infective Drugs Market Value Share Analysis, by Country, 2016 and 2025
Figure 81: Middle East & Africa Anti-infective Drugs Market Value Share Analysis, by Type, 2016 and 2025
Figure 82: Middle East & Africa Anti-infective Drugs Market Value Share Analysis, by Anti-bacterial Drugs, 2016 and 2025
Figure 83: Middle East & Africa Anti-infective Drugs Market Value Share Analysis, by Type - Anti-fungal Drugs, 2016 and 2025
Figure highlights market value share of the Anti-infective Drugs Market in Middle East & Africa, by Type –anti-fungal drugs, for 2016 and 2025
Figure 84: Middle East & Africa Anti-infective Drugs Market Value Share Analysis, by Indication, 2016 and 2025
Figure 85: Middle East & Africa Anti-infective Drugs Market Value Share, by Distribution Channel, 2016 and 2025
Figure 86: Middle East & Africa Anti-infective Drugs Market Attractiveness Analysis, by Type, 2017–2025
Figure 87: Middle East & Africa Anti-infective Drugs Market Attractiveness Analysis, by Indication, 2017–2025
Figure 88: Middle East & Africa Anti-infective Drugs Market Attractiveness Analysis, by Distribution Channel, 2017–2025

 

Custom Market Research Services

TMR offers custom market research services that help clients to get information on their business scenario required where syndicated solutions are not enough.

REQUEST CUSTOMIZATION

Antiinfective Drugs Market

Buy Now